Updates to COVID-19 Treatment Rapid Reviews and addition to technical resources on NICD Website

Dear SAMA Members,

Since early in April, the National Essential Medicines List Sub-Committee on COVID-19 has been publishing rapid reviews of evidence available for treatment options for COVID-19.

 
These reviews have aimed to conduct rapid evidence synthesis reports of therapeutics for the management of COVID-19.

The reports provide up-to-date information and guidance based on current evidence and inform the National Clinical Guidelines for the Clinical Management of suspected or confirmed COVID-19 disease.

Since the last SAMA notification and update in early July (newsletter 3 July), several updates have been made including:

Interferons - not recommended (31 July)
Colchicine - not recommended (6 August)

Most of the rapid evidence reviews have been conducted for seriously ill or hospitalised patient groups, where evidence is the strongest.

Please access the rapid reviews at http://www.health.gov.za/index.php/national-essential-medicine-list-committee-nemlc/category/633-covid-19-rapid-reviews

In addition, the link to the rapid reviews has been added to the Technical Guidance Documents on the NICD website: https://www.nicd.ac.za/diseases-a-z-index/covid-19/covid-19-resources/

Questions? Queries? Please share with us at covid19@samedical.org

The South African Medical Association - Postal Address-The South African Medical Association P O Box 74789,Lynnwood Ridge Pretoria 0040, South Africa Physical address The South African Medical Association, Block F Castle Walk Corporate Park Nossob Street Erasmuskloof Ext3 Pretoria 0181,
South Africa www.samedical.org

If you no longer wish to receive these emails, simply click on the following link Unsubscribe.